Effects of anesthesia with isoflurane, ketamine, or propofol on physiologic parameters in neonatal rhesus macaques (Macaca mulatta)

Journal of the American Association for Laboratory Animal Science

Volumn 53, Issue 3, 2014, Pages 290-300

  Martin, Lauren D ^a   Dissen, Gregory A ^a   McPike, Matthew J ^a   Brambrink, Ansgar M ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLURANE; KETAMINE; KETATHESIA; PROPOFOL; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL WELLBEING; ARTICLE; BLOOD GAS; BLOOD SAMPLING; BREATHING RATE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EXPOSURE; END TIDAL CARBON DIOXIDE TENSION; EXTUBATION; FEMALE; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMICS; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NEWBORN; NONHUMAN; OXYGEN SATURATION; RHESUS MONKEY; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TEMPERATURE; VENOUS BLOOD;

ANESTHETICS; ANIMALS; ANIMALS, NEWBORN; ISOFLURANE; KETAMINE; MACACA MULATTA; PROPOFOL; RANDOM ALLOCATION; VITAL SIGNS;

EID: 84900560850     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Abel K. 2009. The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV1 pathogenesis and for designing pediatric HIV1 prevention strategies. Curr HIV Res 7:2-11.
2. Akata T. 2007. General anesthetics and vascular smooth muscle. Anesthesiology 106:365-391.
3. Akata T, Kanna T, Yoshino J, Takahashi S. 2003. Mechanisms of direct inhibitory action of isoflurane on vascular smooth muscle of mesenteric resistance arteries. Anesthesiology 99:666-677.
4. Allegaert K, De Hoon J, Verbesselt R, Naulers G, Murat I. 2007. Maturational pharmacokinetics of single intravenous bolus of propofol. Paediatr Anaesth 17:1028-1034.
5. Araya M, Kelleher SL, Arredondo MA, Sierralta W, Vial MT, Uauy R, Lönnerdal B. 2005. Effects of chronic copper exposure during early life in rhesus monkeys. Am J Clin Nutr 81:1065-1071.
6. Authier S, Chaurand F, Legaspi M, Breault C, Troncy E. 2006. Comparison of 3 anesthetic protocols for intraduodenal drug administration using endoscopy in rhesus monkeys (Macaca mulatta). J Am Assoc Lab Anim Sci 45:73-79.
7. Bergman SA. 1999. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog 46:10-20.
8. Brambrink AM, Back SA, Riddle A, Gong X, Moravec MD, Dissen GA, Creely CE, Dikranian KT, Olney JW. 2012. Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol 72:525-535.
9. Brambrink AM, Evers AS, Avidan MS, Farber NB, Smith DJ, Martin LD, Dissen GA, Creeley CE, Olney JW. 2012. Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology 116:372-384.
10. Brown VD, Landers S. 2011. Heat balance, p 113-133. In: Carter BS, Enzman-Hines M, Gardner SL, Hernandez JA, editors. Merenstein and Gardner's handbook of neonatal intensive care, 7th ed. St Louis (MO): Mosby Elsevier.
11. Buschbach D, Cotton CM, Miller-Bell M. 2011. Pharmacology in neonatal care, p 184-200. In: Carter BS, Enzman-Hines M, Gardner SL, Hernandez JA, editors. Merenstein and Gardner's handbook of neonatal intensive care, 7th ed. St Louis (MO): Mosby Elsevier.
12. Champoux M, Hibbeln JR, Shannon C, Majchrzak S, Suomi SJ, Salem N Jr, Higley JD. 2002. Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. Pediatr Res 51:273-281.
13. Creeley C, Dikranian KT, Dissen GA, Martin LD, Olney JW, Brambrink AM. 2013. Propofol-induced apoptosis of neurons and oligodendrocytes in the fetal and neonatal rhesus macaque brain. Br J Anaesth 110:i29-i38.
14. Cunnane SC, Menard CR, Likhodii SS, Brenna JT, Crawford MA. 1999. Carbon recycling into de novo lipogenesis is a major pathway in neonatal metabolism of linoleate and α-linolenate. Prostaglandins Leukot Essent Fatty Acids 60:387-392.
15. Dettmer AM, Houser LA, Ruppenthal GC, Capuano S, Hewitson L. 2007. Growth and developmental outcomes of 3 high-risk neonate rhesus macaques (Macaca mulatta). Am J Primatol 69:503-518.
16. Eger EI. 1981. Isoflurane: a review. Anesthesiology 55:559-576.
17. Eger EI. 2004. Characteristics of anesthetic agents used for induction and maintenance of general anesthesia. Am J Health Syst Pharm 61:S3-S10.
18. Engle WD. 2012. Definition of normal blood pressure range: the elusive target, p 49-80. In: Kleinman CS, Seri I, editors. Hemodynamics and cardiology: neonatology questions and controversies, 2nd ed. Philadelphia (PA): Elsevier Saunders.
19. Fish R, Brown M, Danneman P, Karas A, editors. 2008. Anesthesia and analgesia in laboratory animals. London (UK): Elsevier.
20. Fowler KA, Huerkamp MJ, Pullium JK, Subramanian T. 2001. Anesthetic protocol: propofol use in Rhesus macaques (Macaca mulatta) during magnetic resonance imaging with stereotactic head frame application. Brain Res Brain Res Protoc 7:87-93.
21. Gaultier C. 1995. Respiratory muscle function in neonates. Eur Respir J 8:150-153.
22. Gentile MA. 2011. Inhaled medical gases: more to breathe than oxygen. Respir Care 56:1341-1357.
23. Golub MS, Hogrefe CE, Germann SL, Capitanio JP, Lozoff B. 2006. Behavioral consequences of developmental iron deficiency in infant rhesus monkeys. Neurotoxicol Teratol 28:3-17.
24. Gow PJ, Ghabrial H, Smallwood RA, Morgan DJ, Ching MS. 2001. Neonatal hepatic drug elimination. Pharmacol Toxicol 88:3-15.
25. Grant IS, Nimmo WS, McNicol LR, Clements JA. 1983. Ketamine disposition in children and adults. Br J Anaesth 55:1107-1111.
26. Haeseler G, Karst M, Foadi N, Gudehus S, Roeder A, Hecker H, Dengler R, Leuwer M. 2008. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. Br J Pharmacol 155:265-275.
27. Heath-Lange S, Ha JC, Sackett GP. 1999. Behavioral measurement of temperament in male nursery-raised neonate macaques and baboons. Am J Primatol 47:43-50.
28. Hertzog JH, Campbell JK, Dalton HJ, Hauser GJ. 1999. Propofol anesthesia for invasive procedures in ambulatory and hospitalized children: experience in the pediatric intensive care unit. Pediatrics 103:E30.
29. Hewitson L, Houser LA, Stott C, Sackett G, Tomko JL, Atwood D, Blue L, White ER. 2010. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. J Toxicol Environ Health A 73:1298-1313.
30. Hotchkiss CE, Wang C, Slikker W Jr. 2007. Effect of prolonged ketamine exposure on cardiovascular physiology of pregnant and neonate rhesus monkeys (Macaca mulatta). J Am Assoc Lab Anim Sci 46:21-28.
31. Jasiak KD, Phan H, Christich AC, Edwards CJ, Skrepnek GH, Patanwala AE. 2012. Induction dose of propofol for pediatric patients undergoing procedural sedation in the emergency department. Pediatr Emerg Care 28:440-442.
32. Kelleher SL, Casas I, Carbajal N, Lönnerdal B. 2002. Supplementation of infant formula with the probiotic lactobacillus reuteri and zinc: impact on enteric infection and nutrition in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 35:162-168.
33. Kelleher SL, Chatterton D, Nielsen K, Lönnerdal B. 2003. Glycomacropeptide and alpha-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am J Clin Nutr 77:1261-1268.
34. Kluckow M, Evans L. 2000. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 82:F188-F194.
35. Kofke WA, Young RS, Davis P, Woelfel SK, Gray L, Johnson D, Gelb A, Meeke R, Warner DS, Pearson KS. 1989. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 71:653-659.
36. McKeage K, Perry CM. 2003. Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 17:235-272.
37. Miyabe-Nishiwaki T, Masui K, Kaneko A, Nishiwaki K, Shimbo E, Kanazawa H. 2010. Hypnotic effects and pharmacokinetics of a single bolus dose of propofol in Japanese macaques (Macaca fuscata). Vet Anaesth Analg 37:501-510.
38. Morton NS, Johnston G, White M, Marsh BJ. 1992. Propofol in paediatric anaethesia. Paediatr Anaesth 2:89-97.
39. Ng CT, Jaworski JP, Jayaraman P, Sutton WF, Delio P, Kuller L, Anderson D, Landucci G, Richardson BA, Burton DR, Forthal DN, Haigwood NL. 2010. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in neonate macaques. Nat Med 16:1117-1119.
40. Polberger S, Fletcher MP, Graham TW, Vruwink K, Gershwin ME, Lönnerdal B. 1996. Effect of infant formula zinc and iron levels on zinc absorption, zinc status, and immune function in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 22:134-143.
41. Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A. 1996. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm neonate rhesus monkeys. Pediatr Res 39:715-724.
42. Sainsbury AW, Eaton BD, Cooper JE. 2008. An investigation into the use of propofol (Rapinovet) in long?tailed macaques (Macaca fascicularis). Vet Anaesth Analg 18:38-41.
43. Tarantal AF, Marthas ML, Shaw JP, Cundy K, Bischofberger N. 1999. Administration of 9-[2-(R)-(phosphonomethoxy)propyl] adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies. J Acquir Immune Defic Syndr Hum Retrovirol 20:323-333.
44. Trapani G, Altomare C, Sanna E, Biggio G, Liso G. 2000. Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 7:249-271.
45. Van Rompay KK, Berardi CJ, Aguirre NL, Bischofberger N, Lietman PS, Pedersen NC, Marthas ML. 1998. Two doses of PMPA protect newborn macaques against oral SIV infection. AIDS 12:F79-F83.
46. Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, Evans T, Earl P, Harvey D, Franchini G, Tartaglia J, Montefiori D, Hattangadi S, Moss B, Marthas ML. 2005. Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr 38:124-134.
47. Van Rompay KK, Cherrington JM, Marthas ML, Lamy PD, Dailey PJ, Canfield DR, Tarara RP, Bischofberger N, Pedersen NC. 1999. 9-[2-(Phosphonomethoxy) propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA. Antimicrob Agents Chemother 43:802-812.
48. Van Rompay KK, Greenier JL, Cole KS, Earl P, Moss B, Steckbeck JD, Pahar B, Rourke T, Montelaro RC, Canfield DR, Tarara RP, Miller C, McChesney MB, Marthas ML. 2003. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol 77:179-190.
49. Van Rompay KK, Kearney BP, Sexton JJ, Colón R, Lawson JR, Blackwood EJ, Lee WA, Bischofberger N, Marthas ML. 2006. Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus. J Acquir Immune Defic Syndr 43:6-14.
50. Waldron S, MacKinnon R. 2007. Neonatal thermoregulation. Infant 3:101-104.
51. Wang X, Xu H, Pahar B, Alvarez X, Green LC, Dufour J, Moroney-Rasmussen T, Lackner AA, Veazey RS. 2010. Simian immunodeficiency virus selectively infects proliferating CD4+ T cells in neonatal rhesus macaques. Blood 116:4168-4174.
52. Wolf WJ, Neal MB, Peterson MD. 1986. The hemodynamic and cardiovascular effects of isoflurane and halothane anesthesia in children. Anesthesiology 64:328-333.